Home / Partnerships / ImmunoSignatures


HealthTell has numerous relationships with major biopharmaceutical firms to facilitate clinical drug development.
HealthTell’s ImmunoSignature libraries provide the capability to monitor a person’s humoral immune response by providing binding events indicative of both active immune system physiology and memory. 

ImmunoSignatures are accessible in many sample types and aid in biopharmaceutical trials by: informing patient selection, predicting response to therapeutics and indicating possible adverse events.   

Biopharmaceutical firms include HelathTell ImmunoSignature measurements as part of their clinical trial, starting as early as phase I- phase 4. Analysis of samples will be available in days or, as specified by clinical protocols.

  • Stratified Patients
  • Identifies Treatment Responders
  • Indicates Patients with Adverse Events

To learn more about how to partner with HealthTell, contact us!